Source link : https://www.newshealth.biz/health-news/no-single-antipsychotic-offers-cognitive-benefit-in-schizophrenia-disorders/
No individual antipsychotic was associated with better cognitive outcomes than placebo in patients with schizophrenia spectrum disorders (SSD), according to a systematic review and network meta-analysis. However, the study revealed that two first-generation dopamine antagonists — haloperidol (standardized mean difference [SMD] 0.04, 95% CI −0.25 to 0.33) and fluphenazine (SMD 0.15, 95% CI −0.39 to […]
Author : News Health
Publish date : 2024-10-16 19:03:58
Copyright for syndicated content belongs to the linked Source.